Chronic treatment with prednisolone represses the circadian oscillation of clock gene expression in mouse peripheral tissues

Satoru Koyanagi, Sumako Okazawa, Yukako Kuramoto, Kentarou Ushijima, Hiroshi Shimeno, Shinji Soeda, Hitoshi Okamura, Shigehiro Ohdo

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Although altered homeostatic regulation, including disturbance of 24-h rhythms, is often observed in the patients undergoing glucocorticoid therapy, the mechanisms underlying the disturbance remains poorly understood. We report here that chronic treatment with a synthetic glucocorticoid, prednisolone (PSL), can cause alteration of circadian clock function at molecular level. Treatment of cultured hepatic cells (HepG2) with PSL induced expression of Period1 (Per1), and the PSL treatment also attenuated the serum-induced oscillations in the expression of Period2 (Per2), Rev-erbα, and Bmal1 mRNA in HepG2 cells. Because the attenuation of clock gene oscillations was blocked by pretreating the cells with a Per1 antisense phosphothioate oligodeoxynucleotide, the extensive expression of Per1 induced by PSL may have resulted in the reduced amplitude of other clock gene oscillations. Continuous administration of PSL into mice constitutively increased the Per1 mRNA levels in liver and skeletal muscle, which seems to attenuate the oscillation in the expressions of Per2, Rev-erbα, and Bmal1. However, a single daily administration of PSL at the time of day corresponding to acrophase of endogenous glucocorticoid levels had little effect on the rhythmic expression of clock genes. These results suggest a possible pharmacological action by PSL on the core circadian oscillation mechanism and indicate the possibility that the alteration of clock function induced by PSL can be avoided by optimizing the dosing schedule.

Original languageEnglish
Pages (from-to)573-583
Number of pages11
JournalMolecular Endocrinology
Volume20
Issue number3
DOIs
Publication statusPublished - Mar 1 2006

Fingerprint

Circadian Clocks
Prednisolone
Gene Expression
Glucocorticoids
Therapeutics
Messenger RNA
Oligodeoxyribonucleotides
Hep G2 Cells
Genes
Hepatocytes
Cultured Cells
Appointments and Schedules
Skeletal Muscle
Pharmacology
Liver
Serum

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Endocrinology

Cite this

Chronic treatment with prednisolone represses the circadian oscillation of clock gene expression in mouse peripheral tissues. / Koyanagi, Satoru; Okazawa, Sumako; Kuramoto, Yukako; Ushijima, Kentarou; Shimeno, Hiroshi; Soeda, Shinji; Okamura, Hitoshi; Ohdo, Shigehiro.

In: Molecular Endocrinology, Vol. 20, No. 3, 01.03.2006, p. 573-583.

Research output: Contribution to journalArticle

Koyanagi, Satoru ; Okazawa, Sumako ; Kuramoto, Yukako ; Ushijima, Kentarou ; Shimeno, Hiroshi ; Soeda, Shinji ; Okamura, Hitoshi ; Ohdo, Shigehiro. / Chronic treatment with prednisolone represses the circadian oscillation of clock gene expression in mouse peripheral tissues. In: Molecular Endocrinology. 2006 ; Vol. 20, No. 3. pp. 573-583.
@article{96c75696eb7e42989e88f792b6b575e3,
title = "Chronic treatment with prednisolone represses the circadian oscillation of clock gene expression in mouse peripheral tissues",
abstract = "Although altered homeostatic regulation, including disturbance of 24-h rhythms, is often observed in the patients undergoing glucocorticoid therapy, the mechanisms underlying the disturbance remains poorly understood. We report here that chronic treatment with a synthetic glucocorticoid, prednisolone (PSL), can cause alteration of circadian clock function at molecular level. Treatment of cultured hepatic cells (HepG2) with PSL induced expression of Period1 (Per1), and the PSL treatment also attenuated the serum-induced oscillations in the expression of Period2 (Per2), Rev-erbα, and Bmal1 mRNA in HepG2 cells. Because the attenuation of clock gene oscillations was blocked by pretreating the cells with a Per1 antisense phosphothioate oligodeoxynucleotide, the extensive expression of Per1 induced by PSL may have resulted in the reduced amplitude of other clock gene oscillations. Continuous administration of PSL into mice constitutively increased the Per1 mRNA levels in liver and skeletal muscle, which seems to attenuate the oscillation in the expressions of Per2, Rev-erbα, and Bmal1. However, a single daily administration of PSL at the time of day corresponding to acrophase of endogenous glucocorticoid levels had little effect on the rhythmic expression of clock genes. These results suggest a possible pharmacological action by PSL on the core circadian oscillation mechanism and indicate the possibility that the alteration of clock function induced by PSL can be avoided by optimizing the dosing schedule.",
author = "Satoru Koyanagi and Sumako Okazawa and Yukako Kuramoto and Kentarou Ushijima and Hiroshi Shimeno and Shinji Soeda and Hitoshi Okamura and Shigehiro Ohdo",
year = "2006",
month = "3",
day = "1",
doi = "10.1210/me.2005-0165",
language = "English",
volume = "20",
pages = "573--583",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Chronic treatment with prednisolone represses the circadian oscillation of clock gene expression in mouse peripheral tissues

AU - Koyanagi, Satoru

AU - Okazawa, Sumako

AU - Kuramoto, Yukako

AU - Ushijima, Kentarou

AU - Shimeno, Hiroshi

AU - Soeda, Shinji

AU - Okamura, Hitoshi

AU - Ohdo, Shigehiro

PY - 2006/3/1

Y1 - 2006/3/1

N2 - Although altered homeostatic regulation, including disturbance of 24-h rhythms, is often observed in the patients undergoing glucocorticoid therapy, the mechanisms underlying the disturbance remains poorly understood. We report here that chronic treatment with a synthetic glucocorticoid, prednisolone (PSL), can cause alteration of circadian clock function at molecular level. Treatment of cultured hepatic cells (HepG2) with PSL induced expression of Period1 (Per1), and the PSL treatment also attenuated the serum-induced oscillations in the expression of Period2 (Per2), Rev-erbα, and Bmal1 mRNA in HepG2 cells. Because the attenuation of clock gene oscillations was blocked by pretreating the cells with a Per1 antisense phosphothioate oligodeoxynucleotide, the extensive expression of Per1 induced by PSL may have resulted in the reduced amplitude of other clock gene oscillations. Continuous administration of PSL into mice constitutively increased the Per1 mRNA levels in liver and skeletal muscle, which seems to attenuate the oscillation in the expressions of Per2, Rev-erbα, and Bmal1. However, a single daily administration of PSL at the time of day corresponding to acrophase of endogenous glucocorticoid levels had little effect on the rhythmic expression of clock genes. These results suggest a possible pharmacological action by PSL on the core circadian oscillation mechanism and indicate the possibility that the alteration of clock function induced by PSL can be avoided by optimizing the dosing schedule.

AB - Although altered homeostatic regulation, including disturbance of 24-h rhythms, is often observed in the patients undergoing glucocorticoid therapy, the mechanisms underlying the disturbance remains poorly understood. We report here that chronic treatment with a synthetic glucocorticoid, prednisolone (PSL), can cause alteration of circadian clock function at molecular level. Treatment of cultured hepatic cells (HepG2) with PSL induced expression of Period1 (Per1), and the PSL treatment also attenuated the serum-induced oscillations in the expression of Period2 (Per2), Rev-erbα, and Bmal1 mRNA in HepG2 cells. Because the attenuation of clock gene oscillations was blocked by pretreating the cells with a Per1 antisense phosphothioate oligodeoxynucleotide, the extensive expression of Per1 induced by PSL may have resulted in the reduced amplitude of other clock gene oscillations. Continuous administration of PSL into mice constitutively increased the Per1 mRNA levels in liver and skeletal muscle, which seems to attenuate the oscillation in the expressions of Per2, Rev-erbα, and Bmal1. However, a single daily administration of PSL at the time of day corresponding to acrophase of endogenous glucocorticoid levels had little effect on the rhythmic expression of clock genes. These results suggest a possible pharmacological action by PSL on the core circadian oscillation mechanism and indicate the possibility that the alteration of clock function induced by PSL can be avoided by optimizing the dosing schedule.

UR - http://www.scopus.com/inward/record.url?scp=33344456741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33344456741&partnerID=8YFLogxK

U2 - 10.1210/me.2005-0165

DO - 10.1210/me.2005-0165

M3 - Article

C2 - 16269518

AN - SCOPUS:33344456741

VL - 20

SP - 573

EP - 583

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 3

ER -